Slow metabolizers allow toxic levels of drugs like hydroxychloroquine to accumulate resulting in increased cardiac complications like prolonged QTc syndrome, with increased risk of cardiac death, particularly in obesity and diabetes, where ACE-2 is upregulated (Figure 7) due to an increase of white adipocytes and a reduction in brown adipocytes. The gene discussed is ACE2; the disease is obesity disorder.